These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8348101)

  • 1. Consensus conference on measles.
    Can Commun Dis Rep; 1993 May; 19(10):72-9. PubMed ID: 8348101
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 3. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J
    CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for measles control in Canada.
    CMAJ; 1991 Apr; 144(8):997-1000. PubMed ID: 2009478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles--United States, 1996, and the interruption of indigenous transmission.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):242-6. PubMed ID: 9082179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles--Puerto Rico, 1993, and the measles elimination program.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):171-3. PubMed ID: 8164642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles control.
    Durham G
    N Z Med J; 1997 Jul; 110(1047):259. PubMed ID: 9251716
    [No Abstract]   [Full Text] [Related]  

  • 10. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 12. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 15. Contraindications to live-viral immunization.
    Legler JD
    J Fam Pract; 1989 Mar; 28(3):333-4. PubMed ID: 2926350
    [No Abstract]   [Full Text] [Related]  

  • 16. The costs of preventing measles.
    Nassau RD
    JAMA; 1992 Feb; 267(5):655-6. PubMed ID: 1731130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles-mumps-rubella vaccination. Objective: 90% vaccinal coverage at 2 years of age in France].
    Lacronique JF; Janvrin MP
    Sante; 1994; 4(3):213. PubMed ID: 7921690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.